Literature DB >> 16487147

LRRK2 is expressed in areas affected by Parkinson's disease in the adult mouse brain.

Javier Simón-Sánchez1, Vicente Herranz-Pérez, Francisco Olucha-Bordonau, Jordi Pérez-Tur.   

Abstract

The leucine-rich repeat kinase 2 (LRRK2) gene was recently found to have multiple mutations that are causative for autosomal dominant inherited Parkinson's disease (PD). Previously, we used Northern blot analysis to show that this gene was expressed in the cerebellum, cerebral cortex, medulla, spinal cord, occipital pole, frontal lobe, temporal lobe and caudate putamen. However, a more comprehensive map of LRRK2 mRNA localization in the central nervous system is still lacking. In this study we have mapped the distribution of the mRNA encoding for LRRK2 using nonradioactive in situ hybridization. We detected a moderate expression of this PD-related gene throughout the adult B2B6 mouse brain. A stronger hybridization signal was observed in deep cerebral cortex layers, superficial cingulate cortex layers, the piriform cortex, hippocampal formation, caudate putamen, substantia nigra, the basolateral and basomedial anterior amygdala nuclei, reticular thalamic nucleus and also in the cerebellar granular cell layer. Given that LRRK2 mRNA is highly enriched in motor systems and also is expressed in other systems, we may conclude that mutations in LRRK2 may affect several motor and nonmotor structures that may play an important role in the development of PD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16487147     DOI: 10.1111/j.1460-9568.2006.04616.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  29 in total

Review 1.  Parkinson's disease: a rethink of rodent models.

Authors:  Heather L Melrose; Sarah J Lincoln; Glenn M Tyndall; Matthew J Farrer
Journal:  Exp Brain Res       Date:  2006-04-26       Impact factor: 1.972

2.  Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents.

Authors:  Andrew B West; Rita M Cowell; João P L Daher; Mark S Moehle; Kelly M Hinkle; Heather L Melrose; David G Standaert; Laura A Volpicelli-Daley
Journal:  J Comp Neurol       Date:  2014-04-12       Impact factor: 3.215

3.  Lrrk2 localization in the primate basal ganglia and thalamus: a light and electron microscopic analysis in monkeys.

Authors:  H Lee; H L Melrose; M Yue; Jean-Francois Pare; M J Farrer; Y Smith
Journal:  Exp Neurol       Date:  2010-05-17       Impact factor: 5.330

Review 4.  α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease.

Authors:  Jason P Covy; Benoit I Giasson
Journal:  Neurotoxicology       Date:  2011-01-14       Impact factor: 4.294

5.  LRRKing up the right trees? On figuring out the effects of mutant LRRK2 and other Parkinson's disease-related genes.

Authors:  Heinz Steiner
Journal:  Basal Ganglia       Date:  2013-07-01

Review 6.  Synaptic dysfunction in genetic models of Parkinson's disease: a role for autophagy?

Authors:  Edward D Plowey; Charleen T Chu
Journal:  Neurobiol Dis       Date:  2010-10-20       Impact factor: 5.996

7.  The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.

Authors:  Saurabh Sen; Andrew B West
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

8.  Update on the functional biology of Lrrk2.

Authors:  Heather Melrose
Journal:  Future Neurol       Date:  2008

9.  LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's disease.

Authors:  J Alegre-Abarrategui; O Ansorge; M Esiri; R Wade-Martins
Journal:  Neuropathol Appl Neurobiol       Date:  2007-10-26       Impact factor: 8.090

10.  Expression of the LRRK2 gene in the midbrain dopaminergic neurons of the substantia nigra.

Authors:  Baek-Soo Han; Lorraine Iacovitti; Taku Katano; Nobutaka Hattori; Wongi Seol; Kwang-Soo Kim
Journal:  Neurosci Lett       Date:  2008-07-10       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.